Sept 17, 2014
“TKM-Ebola, an anti-Ebola virus RNAi therapeutic, is being developed under a $140 million contract with the U.S. Department of Defense’s Medical Countermeasure Systems BioDefense Therapeutics (MCS-BDTX) Joint Product Management Office”. As breaking and shocking of a news story as this has the potential to be, the real story is that this is not the most important part of the Ebola threat which has invaded the United States. The truth of the matter is that these unholy and untrustworthy associations, when it comes to “fighting” the Ebola virus, represent the mere tip of the iceberg.
The more on digs into who is behind the creation and the development of vaccines for treating Ebola, the more the conspiracy networks widen. The most amazing fact is how incredibly easy it was to locate this information. I want to be clear on this point, Ebola was invented, a vaccine for Ebola has existed for 8-10 years, some government sponsored institutions as well as some of the global elite have positioned themselves to profit enormously from the spread of the virus and the development of and dissemination of mandatory Ebola vaccines and the imposition of total martial law in the process. Here is the proof.
Human ebola virus species and compositions and methods thereof
Amazingly, the CDC owns “the” patent on Ebola and all future strains.
CA 2741523 A1
The “SUMMARY OF THE INVENTION” section of the patent document also clearly claims that the U.S. government is claiming “ownership” over all Ebola viruses that share as little as 70% similarity with the Ebola it “invented”:
Why would a government organization claim to have “invented” this infectious disease and then claim a monopoly over its exploitation for commercial use? It is clear that the CDC plans to claim royalties on Ebola vaccines. This certainly increases the likelihood that the vaccines will become mandatory, thus increasing the profit potential for the patent holders.
|Publication number||CA2741523 A1|
|Application number||CA 2741523|
|Publication date||Apr 29, 2010|
|Filing date||Oct 26, 2009|
|Priority date||Oct 24, 2008|
|Also published as||EP2350270A2, 4 More »|
|Inventors||Jonathan S. Towner, Stuart T. Nichol, James A. Comer, Thomas G. Ksiazek, Pierre E. Rollin|
|Applicant||Jonathan S. Towner, 5 More »|
|Export Citation||BiBTeX, EndNote, RefMan|
|Classifications (21), Legal Events (1)|
|External Links: CIPO, Espacenet|
Clearly, Ebola is manmade and this patent proves this contention. Why does the CDC need to own the patent on Ebola? Perhaps, we should ask Bill Gates why he is donating $50 million to the UN and the CDC in the name of fighting Ebola (see video below). The CDC has partners in the fight against Ebola, namely, Crucell, the National Institute of Health (NIH) and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and, of course, Bill and Melinda Gates.
Since when would Gates not expect a return on his investment? Gates and Michael Bloomberg have already contributed large sums of money to numerous vaccination causes such as the Global Polio Eradication Initiative originally launched in 1988 by the World Health Organization (WHO), Rotary International, Centers for Disease Control and Prevention (CDC), and the United Nations Children’s Fund (UNICEF). The return on investment has been impressive.
Gates has announced that he plans to vaccinate every child in the third world with multiple vaccines, which could result in a dramatic population reduction of 10-15%. Do you realize the enormous profits that can be realized by vaccinating every child in the third world? If we apply Gates’ penchant for investing in causes which produce a hefty “return on investment” (ROI) then one could reasonably suspect that Gates is positioning himself to profit on the $50 million he has invested in the Ebola cause which conveniently includes the CDC, the holder of the patent for Ebola.
The NIH presently holds all patents on Ebola vaccines. Crucell is much like Tekimara is to Monsanto in that they are fronting the science for the Ebola vaccine treatment patents.